Metabolomics of sebum reveals lipid dysregulation in Parkinson’s disease
Studies of metabolites in neurodegeneration have not yet used sebum as a source fluid. Here the authors demonstrate the potential of metabolomics of sebum samples from individuals with Parkinson’s disease and controls.
Guardado en:
Autores principales: | Eleanor Sinclair, Drupad K. Trivedi, Depanjan Sarkar, Caitlin Walton-Doyle, Joy Milne, Tilo Kunath, Anouk M. Rijs, Rob M. A. de Bie, Royston Goodacre, Monty Silverdale, Perdita Barran |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9e01bc89a95e413fbdff0e9ee7e5a51b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Metabolic dysregulation in vitamin E and carnitine shuttle energy mechanisms associate with human frailty
por: Nicholas J. W. Rattray, et al.
Publicado: (2019) -
Non-invasive diagnostic tool for Parkinson’s disease by sebum RNA profile with machine learning
por: Yuya Uehara, et al.
Publicado: (2021) -
Lipidomics of facial sebum in the comparison between acne and non-acne adolescents with dark skin
por: Obumneme Emeka Okoro, et al.
Publicado: (2021) -
Author Correction: Lipidomics of facial sebum in the comparison between acne and non-acne adolescents with dark skin
por: Obumneme Emeka Okoro, et al.
Publicado: (2021) -
Mass spectrometry locates local and allosteric conformational changes that occur on cofactor binding
por: Rebecca Beveridge, et al.
Publicado: (2016)